Late-onset and atypical presentation of Pneumocystis carinii pneumonia in a renal transplant recipient

Clinical and Experimental Nephrology

Volumn 13, Issue 1, 2009, Pages 92-95

  Li, Jordan Y Z ^a,c   Yong, Tuck Y ^a   Grove, David I ^a,b   Coates, P Toby H ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Immunosuppression; Kidney transplant; Opportunistic infection; Pneumocystis jivorecii pneumonia

Indexed keywords

COTRIMOXAZOLE; OKT 3; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ADULT; ANAMNESIS; ARTICLE; BRONCHOSCOPY; BRONCHUS BIOPSY; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS; DRUG MEGADOSE; GRAFT REJECTION; HUMAN; KIDNEY GRAFT; MALE; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA;

ANTI-INFECTIVE AGENTS; BRONCHOSCOPY; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLEURAL EFFUSION; PNEUMONIA, PNEUMOCYSTIS; PREDNISOLONE; RADIOGRAPHY, THORACIC; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUBERCULOSIS, PULMONARY;

EID: 59449090722     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-008-0079-9     Document Type: Article

References (17)

1. JA Fishman 1995 Pneumocystis carinii and parasitic infection in transplantation Infect Dis Clin North Am 9 1005 44
2. SM Gordon SP LaRosa S Kalmadi AC Arroliga RK Avery L Truesdell-LaRosa DL Longworth 1999 Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipient ever be discontinued? Clin Infect Dis 28 240 6
3. FW Ballardie CG Winearls J Cohen DH Carr AJ Rees G Williams 1985 Pneumocystis carinii pneumonia in renal transplant recipients-clinical and radiographic features, diagnosis and complications of treatment QJM 223 729 47
4. SM Arend FP Kroon JW van't Wout 1995 Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993 Arch Intern Med 155 2436 41
5. R Nüesch C Bellini W Zimmerli 1999 Pneumocystis carinii pneumonia in human immunodeficiency (HIV)-positive and HIV-negative immunocompromised patients Clin Infect Dis 29 1519 23
6. M Radisic R Lattes JF Chapman M del Carmen Rial O Guardia F Seu P Gutierrez J Goldberg DH Casadei 2003 Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study Transpl Infect Dis 5 84 93
7. JG Gerrard 1995 Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults Med J Aust 162 233
8. AM Hardy CP Wajszcuk AF Suffredini TR Hakala M Ho 1984 Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids J Infect Dis 149 143 7
9. V Lufft V Kliem M Behrend R Pichlmayr KM Koch R Brunkhorst 1996 Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression Transplantation 62 421 3
10. BD Kahan BA Julian MD Pescovitz Y Vanrenterghem J Neylan 1999 Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group Transplantation 68 1526 32
11. J Dominguez K Mahalati B Kiberd VC McAlister AS MacDonald 2000 Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience Transplantation 70 1244 7
12. European Mycophenolate Mofetil Cooperative Study Group 1995 Placebo-controlled study of mycophenolate mofetil combined cyclosporin and corticosteroids for prevention of acute rejection Lancet 345 1321 5
13. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. US Renal Transplant Mycophenolate Mofetil Study Group. Transplantation. 1995;60:225-32.
14. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group 1996 A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation Transplantation 61 1029 37
15. Sato T, Inokuma S, Maezawa R, et al. Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseases. Mod Rheumatol. 2005;15:191-7.
16. Briel M, Boscacci R, Furrer H, Bucher HC. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials. BMC Infec Dis. 2005;5:101.
17. Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest. 1998;113:1215-24.